[Management of erectile dysfunction in patients with preexisting cardiovascular disease]

Area of Science:

• Cardiology
• Urology
• Internal Medicine

Context:

• Erectile dysfunction (ED) is highly prevalent in patients with cardiovascular diseases (CVD).
• Sexual dysfunction often precedes the clinical manifestation of CVD, suggesting a shared underlying pathology.
• ED and CVD may represent clinical manifestations of a common systemic disease process.

Purpose:

• To explore the intricate relationship between ED and CVD.
• To highlight the importance of considering ED as a potential cardiovascular risk factor.
• To guide clinical management strategies for patients with co-existing ED and CVD.

Summary:

• ED and CVD share common pathophysiological mechanisms and risk factors.
• Patients with both conditions require cardiovascular risk stratification before initiating sexual activity.
• Pro-erectile medications are safe for low-risk CVD patients, while high-risk patients need cardiac stabilization first.
• Lifestyle modifications, PDE5 inhibitors, and testosterone therapy show promise in improving sexual function and reducing CVD risk.

Impact:

• Emphasizes the need for a unified approach to managing ED and CVD.
• Promotes early identification of cardiovascular risk through sexual health assessment.
• Informs evidence-based treatment guidelines for a significant patient population.
• Highlights potential therapeutic strategies for improving both sexual health and cardiovascular outcomes.